SOX2 and hepatocellular carcinoma: A synergistic action of Sox2 and TAZ has been reported in hepatocellular carcinoma (HCC) not only to promote cell proliferation but also to promote the epithelial-to-mesenchymal transition (EMT) for the initiation of metastatic invasion [54].